For a patient presenting with abdominal bloating and diarrhea, which laboratory tests should be ordered and what treatment is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing and Treatment for Abdominal Bloating and Diarrhea

For a patient with abdominal bloating and diarrhea, you should order: (1) IgA tissue transglutaminase with total IgA level for celiac disease, (2) Giardia antigen test or PCR, and (3) fecal calprotectin to screen for inflammatory bowel disease. 1

Initial Laboratory Workup

The 2019 AGA guidelines provide clear, evidence-based testing recommendations for chronic diarrhea that directly apply to your patient:

Strong Recommendations (Must Order):

  • Celiac disease testing: IgA tissue transglutaminase (IgA-tTG) with total IgA level

    • Sensitivity and specificity both >90% 1
    • If IgA deficient, add IgG tissue transglutaminase or IgG deaminated gliadin peptides 1
    • Positive results require duodenal biopsy confirmation 1
  • Giardia testing: Antigen test or PCR (NOT ova and parasites)

    • Sensitivity and specificity >95% 1
    • This is a strong recommendation with high-quality evidence 1
    • Giardia is a common, readily treatable cause of watery diarrhea throughout the US 1

Conditional Recommendations (Should Consider):

  • Fecal calprotectin or fecal lactoferrin to screen for inflammatory bowel disease
    • Use instead of ESR or CRP, which have poor diagnostic accuracy 1
    • If these tests are unavailable or not covered by insurance, CRP may be considered as a fallback option 1

Tests to AVOID:

  • Do NOT order routine ova and parasites testing unless the patient has travel history to or recent immigration from high-risk areas 1
  • Do NOT order ESR or CRP as primary IBD screening (conditional recommendation against) 1
  • Do NOT order serologic tests for IBS diagnosis—they lack diagnostic accuracy 1

Additional Testing Based on Clinical Context

If Bloating is Prominent:

Per the 2023 AGA Clinical Practice Update on bloating 2:

  • Carbohydrate enzyme deficiencies: Rule out with dietary restriction and/or breath testing 2
  • Small intestinal bacterial overgrowth (SIBO): Only in at-risk patients, use small bowel aspiration or glucose/lactulose hydrogen breath testing 2
  • Imaging and endoscopy: Order ONLY if alarm features present (bleeding, unexplained weight loss, age ≥45, nocturnal diarrhea, iron deficiency anemia) 2, 3

Consider Bile Acid Diarrhea Testing:

  • Conditional recommendation to test for bile acid diarrhea 1
  • Practical approach: Since specialized tests (48-hour stool bile acids, serum FGF-19) are not widely available, consider an empiric trial of bile acid binders (cholestyramine, colesevelam) 1
  • Clinical response suggests bile acid diarrhea as the cause 1

Treatment Approach

First-Line Lifestyle Modifications:

Based on recent evidence 3:

  • Regularly scheduled meals
  • Exercise
  • At least 8 cups of noncaffeinated fluids daily
  • Limit caffeine to ≤3 cups daily
  • Avoid alcohol and carbonated beverages

Dietary Interventions:

  • Low FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides, polyols) 3

    • Limit: legumes, wheat, onions, garlic, lactose, fructose, sorbitol, mannitol
    • Should be monitored by a gastroenterology dietitian 2
    • Improves symptoms in 50-80% of patients 3
  • Do NOT use probiotics for bloating and distention 2

Pharmacologic Treatment:

For general chronic diarrhea management 3:

  1. Opiate agonists: Loperamide (first-line antidiarrheal)
  2. Anticholinergics: Hyoscyamine, dicyclomine
  3. 5-HT3 antagonists: Ondansetron

These therapies improve diarrhea in 50-80% of patients 3

For Refractory Cases:

  • Central neuromodulators (tricyclic antidepressants preferred over SSRIs) to reduce visceral hypersensitivity 2, 4
  • Brain-gut behavioral therapies: Cognitive behavioral therapy, hypnotherapy, diaphragmatic breathing 2
  • Biofeedback therapy if pelvic floor disorder identified 2

Common Pitfalls to Avoid:

  1. Over-testing: Don't order comprehensive stool panels, gastric emptying studies, or whole gut motility studies unless specific indications exist 2
  2. Missing celiac disease: Always include IgA-tTG testing—celiac disease is an important treatable cause 1
  3. Ordering ova and parasites: This is low-yield without travel history; order Giardia-specific testing instead 1
  4. Delaying empiric treatment: If initial workup is negative, the most likely diagnosis is IBS-D or functional diarrhea—treat empirically rather than pursuing endless testing 3

When to Escalate Testing:

Order colonoscopy with random biopsies if 3:

  • Age ≥45 years
  • Gastrointestinal bleeding
  • Unexplained weight loss
  • Nocturnal diarrhea
  • Steatorrhea
  • Iron deficiency anemia

Random biopsies during colonoscopy are essential to evaluate for microscopic colitis, which affects 13% of patients with chronic diarrhea despite normal endoscopic appearance 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.